Navigation Links
Neurocrine Biosciences to Present at the 30th Annual Cowen & Co. Health Care Conference
Date:3/8/2010

s.linkTrackVars='prop5,eVar3,prop15';s.prop5='External Link';s.eVar3=s.prop5;s.prop15='86929697';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.neurocrine.com/">http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, irritable bowel syndrome and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neurocrine Biosciences, Inc. Prices Common Stock Offering
2. Neurocrine Announces Proposed Public Offering of Common Stock
3. Neurocrine Advances VMAT2 Inhibitor Program
4. Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
5. Neurocrine Biosciences Reports Third Quarter 2009 Results
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
7. Neurocrine Biosciences Presents Elagolix Data
8. Neurocrine Announces Top-Line Results From 702 Study (Lilac PETAL Study) of Elagolix for Treatment of Endometriosis Pain
9. Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
10. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
11. Neurocrine Biosciences Reports First Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... "Australia Capsule Endoscopy Systems Market Outlook to 2020″, provides ... market. The report provides value, in millions of US ... dollars) within market segments: Photo - ... , Capsule Endoscopy Data Recorders , Capsule Endoscopy ... shares and distribution shares data for each of these ...
(Date:7/25/2014)... 25, 2014  Smile Train and its technology partner ... Virtual Surgery Simulator among leading global health innovations in ... in Washington, D.C. at The ... "Smile Train is honored to be represented ... of innovators in health and medicine that TEDMED unites ...
(Date:7/25/2014)... COSTA MESA, Calif. , July 25, 2014 /PRNewswire-iReach/ ... Peter Nieto as the new Vice President ... industry for over 30 years in a number of ... CROs in the industry. These positions were primarily related ... has obtained over the past 30 years makes him ...
Breaking Medicine Technology:Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5Smile Train and BioDigital Selected to Showcase Virtual Surgery Simulator in The Hive at TEDMED 2014 2Smile Train and BioDigital Selected to Showcase Virtual Surgery Simulator in The Hive at TEDMED 2014 3Contract Research Organization WCCT Global Welcomes Peter Nieto as Vice President of Business Development 2
(Date:7/28/2014)... Top Northridge dentist , Dr. Farshid Ariz, is ... new dentist can be an intimidating experience. Many people struggle ... and worry about how they will connect with a new ... concerns and dental needs and works to ensure that each ... special coupon can help patients get the treatments they need ...
(Date:7/28/2014)... Pittsburgh, PA (PRWEB) July 28, 2014 "I ... slings were ineffective," said an inventor from Sunnyvale, Calif. "When ... The slings on the market are cumbersome and require too ... alternative." , She developed the Multiple Functioning Vest to improve ... shoulder and arm so that they heal properly. This helps ...
(Date:7/28/2014)... HealthDay Reporter FRIDAY, July 25, ... insurance this year will face fines of up to $2,448 ... Internal Revenue Service says. The Obama administration on Thursday ... some Americans will owe for failing to have health insurance. ... national average premium for a bronze-level health plan. ...
(Date:7/28/2014)... Glidewell Laboratories announced today that ... passed the five-year mark in clinical usage, and have ... prescribed by US dentists. , Even as BruxZir Solid ... results from respected clinical studies, many dentists expressed the ... extended years of clinical service before they would elect ...
(Date:7/28/2014)... 2014 Scientists in Japan have completed ... blood test for the asbestos cancer mesothelioma. Surviving Mesothelioma ... Click here to read it now. , ... Juntendo University Graduate School of Medicine say a new ... step above the old test. , “Particularly for ...
Breaking Medicine News(10 mins):Health News:Northridge Dentist, Dr. Farshid Ariz, is Now Offering a $100 Coupon for New Patients 2Health News:IRS Caps Fines on Uninsured Americans at $12K for Family of 5 2Health News:BruxZir® Solid Zirconia Surpasses Five Years of Clinical Use 2Health News:Test Results Look Promising for New Mesothelioma Blood Test, According to Surviving Mesothelioma 2
... Dec. 17 PureCart Systems LLC, announces,the launch of ... system for healthcare facilities. The system, which can ... equipment, patient beds and,rooms, provides a one-step, hospital-grade disinfectant ... require wiping or rinsing. , ...
... 17 EyeScience Labs announces the,availability of its advanced ... eye syndrome at CVS Pharmacy stores ( www.cvs.com ),nationwide. ... http://www.newscom.com/cgi-bin/prnh/20081217/CLW029-a ) , ... This marks the first time EyeScience Macular ...
... Imbach, Former Vice-President of Revenue and Customer Operations at LinkedIn Named ... Design at Yahoo! Named Product Fellow , ... Mountain ... the industry leader in personal genetics , announced today that ...
... receptor controls blood pressure, study shows , , WEDNESDAY, Dec. ... individuals tend to have high blood pressure, but now ... explain that link. , In findings published in the ... Journal of Medicine , Sadaf Farooqi, of the University ...
... In study, those with pulmonary clots saw benefit, , , ... that giving the clot-dissolving drug tenecteplase (TKNase) to people ... the drug, a form of tissue plasminogen activator (tPA), ... haven,t given up on the idea. , "In specific ...
... woman,s face, physicians say , , WEDNESDAY, Dec. 17 (HealthDay ... has completed the nation,s first near-total face transplant. , ... 80 percent of the skin surface of her face, ... essentially everything except the upper eyelids, forehead, lower ...
Cached Medicine News:Health News:PureCart Systems LLC Develops a Portable Disinfecting System for the Healthcare Industry 2Health News:EyeScience's New Ocular Nutrition Supplements Available at CVS Stores 2Health News:Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team 2Health News:Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team 3Health News:Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team 4Health News:Study Finds Molecular Link Between Obesity, Hypertension 2Health News:Study Finds Molecular Link Between Obesity, Hypertension 3Health News:Clot Dissolver Doesn't Boost Survival in Cardiac Arrest Patients 2Health News:Clot Dissolver Doesn't Boost Survival in Cardiac Arrest Patients 3Health News:Doctors Describe First U.S. Face Transplant 2Health News:Doctors Describe First U.S. Face Transplant 3Health News:Doctors Describe First U.S. Face Transplant 4
The large External Fixator consists of rods, clamps, and pins. It has multiple external fixation frames, independent pin placement, and MR safe clamps. The modular frame construction permits fracture...
The DFS Standard Fixator advantages include a highly adjustable system, modular compression/distraction, versatile central body component that provides 360 of rotation, and a positive locking mechani...
For radial/ulnar translation, angulation, dorsal/volar translation, and incremental longitudinal distraction, this advanced system is appropriate when incremental adjustment provides an adjunctive me...
This radiolucent One-piece fixator permits independent mechanical adjustments of the following: Distraction/Compression, Dorsal/Palmar Translation, Radial/Ulnar Translation, Flexion/Extension....
Medicine Products: